Tag: Program
Latest article
SCM Lifescience to in-license iPSCs-based diabetes drug from U.S. agency
SCM Lifescience has agreed to license a diabetes drug that uses pancreatic beta cells derived from induced pluripotent stem cells...
Synthetic pancreas units to assist 1,000 folks with diabetes
The head of the NHS has announced that around 1,000 diabetes patients will get an artificial pancreas.As part of a pilot project, patients with...
